{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-004020","form_type":"8-K","ticker":"ASPI","cik":"0001921865","company_name":"ASP Isotopes Inc.","filed_at":"2026-06-25T21:24:49+00:00","discovered_at":"2026-06-25T21:26:00.311541+00:00","generated_at":"2026-06-25T21:26:22.690695+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"ASPI subsidiary Noble to merge into ENDRA Life Sciences with $50M investment; renamed Noble Africa Inc.","bullets":["Merger: Noble (ASPI subsidiary) merges into ENDRA; each Noble unit converts to one share of Class A or Class B common stock.","Noble Investment: ~$50M gross proceeds from 4.59M Class A units at $6.57/unit to institutional investors and 3.05M Class B units to ASPI.","ASPI contributes its Renergen subsidiary to Noble for 55.5M Class B units, entitling ASPI to 10 votes per share in ENDRA.","Closing conditions include ENDRA stockholder approval, SEC effectiveness, Nasdaq listing, OPIC consent, and ENDRA having ≥$3.8M cash.","Expected closing by Dec 24, 2026; ASPI directors (Mann, Ryan, Ainscow, Moore) subscribe for ~$750K of Noble Class A units."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-004020","json":"https://secwatch.observer/filing/0001477932-26-004020.json","markdown":"https://secwatch.observer/filing/0001477932-26-004020.md","text":"https://secwatch.observer/filing/0001477932-26-004020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1921865/000147793226004020/0001477932-26-004020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1921865/000147793226004020/aspi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:26:22.690695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}